ReviewNatural products and bioprospecting2025
Nitrogen-containing secondary metabolites from Meliaceae Family and their biological activity: a review.
Review in Natural products and bioprospecting, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Distribution and bioactivities of tirucallane-type triterpenoids from Meliaceae family.Natural products and bioprospecting · 2026Review
- Plant-Derived Bioactive Metabolites from the Sonoran Desert: Redox Regulation, Nrf2/NF-κB Signaling, and Emerging Therapeutic Applications.International journal of molecular sciences · 2026Review
- Mitophagy-driven multidimensional regulation of tumor immune evasion and context-dependent therapeutic strategies.Journal of translational medicine · 2026Review
- Targeting Ferroptosis in Sepsis: Therapeutic Potential and Mechanisms of Natural Products and Traditional Chinese Medicine.Journal of inflammation research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The Meliaceae family, widely distributed in tropical and subtropical regions, has been traditionally used for medicinal purposes, particularly in treating infections and inflammatory diseases. The objective of this study is to provide a comprehensive account of the nitrogen-containing secondary metabolites and their biological activities that have been isolated from the Meliaceae family between the years 1979 and 2024. Studies on nitrogen-containing compounds of the Meliaceae family were collected and analyzed using data from SciFinder, PubMed, Google Scholar, Scopus and World Flora Online. Over the course of more than four decades, numerous studies have been conducted on a variety of plant parts, including twigs, stems, barks, roots, fruits, seeds, and leaves. These studies have identified approximately 326 compounds belonging to diverse chemical groups, such as alkaloids, limonoids, triterpenoids, and nitrogen-containing flavaglines being the largest group of natural products, comprising 118 compounds (36.2%). Several compounds have been evaluated for insecticidal, anti-inflammatory, molluscicide, antibacterial, antimalarial, tyrosinase inhibition, osteoclast differentiation inhibition, and α-glucosidase inhibition activity. The systematic classification and analysis of these compounds provide insights into their biosynthesis and bioactivities, paving the way for future drug development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.